Executive Summary
A Roadmap for Early Development to Commercial Manufacturing
Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization.
View Now
Webinars
Strategies for Integrated Business, Regulatory, & Scientific Needs of CMC Clients
Summary: Drug development requires integrating multi-disciplinary business, regulatory and scientific activities. To successfully support a client’s program, it is imperative to provide advice and services that support all three in the context of a program’s goal. In this exclusive webinar presented by Jim Spavins...
View Now
Webinars
Innovative Solutions to Meet the Complex Pharmaceutical Supply Challenges
Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider.
View Now
Webinars
Pharma Predictions for 2021
Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.
View Now
Executive Summary
From Candidate to Clinic: Strategies to Accelerate Your Molecule's Development Path
The development of orally administered small molecules is more challenging as an many have poor aqueous solubility and bioavailability.
View Now
Article
Strategies for De-risking Early-Phase Oral Small Molecule Drug Development
Summary: Characterize lead molecules and develop the best pathway to bring them to Phase I studies and beyond.
View Now
Article
Partnering for Success: Strategies to Mitigate Common Pitfalls in Early Drug Development
Summary: Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact how a drug compound...
View Now
Webinars
Early Drug Development: Strategy and Solution
This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development.
View Now
Webinars
From Development to Commercialization: Overcoming Scale-Up Issues
Summary: Recorded at Manufacturing Chemist Live 2020, this presentation discusses some of the key issues to consider when planning for the scale-up of a small molecule development program.
View Now
Webinars
Discover the Latest Funding, Drug Development and Clinical Solutions Strategies
Summary: Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies.
View Now